Status:
UNKNOWN
Assessment Vitamin D Analogues Intake Pathways on the Proteins Which Involved in Metabolic Rate in Obese Subjects
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Obesity
Eligibility:
All Genders
22-52 years
Phase:
NA
Brief Summary
The aim of this double blind clinical trial study is to investigate whether alphacalcidol treatment in obese subjects can affect the resting metabolic rate. Moreover, the investigators will evaluate t...
Eligibility Criteria
Inclusion
- Age 22-52 years Body mass index equal or more than 30
Exclusion
- Acute or chronic inflammatory disease History of hypertension Alcohol or drug abuse History of any condition affecting inflammatory markers Thyroid diseases Malignancies Current smoking Diabetes mellitus Sustained hypertension Heart failure Acute or chronic infections Hepatic or renal diseases Use of PPARγ agonist drug
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01894295
Start Date
June 1 2012
End Date
September 1 2013
Last Update
July 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TehranUMS
Tehran, Tehran Province, Iran